Comparative efficacy of Chinese patent medicines for non-alcoholic fatty liver disease: A network meta-analysis

Background: The incidence of Non-alcoholic fatty liver disease (NAFLD) is increasing year by year. Researches showed that Chinese patent medicines (CPMs) had achieved good efficacy in the treatment of Non-alcoholic fatty liver disease. However, the debate on optimum Chinese patent medicine (CPM) per...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lihui, Liu, Sutong, Gu, Yajiao, Li, Shanzheng, Liu, Minghao, Zhao, Wenxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847677/
https://www.ncbi.nlm.nih.gov/pubmed/36686656
http://dx.doi.org/10.3389/fphar.2022.1077180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847677/
https://www.ncbi.nlm.nih.gov/pubmed/36686656
http://dx.doi.org/10.3389/fphar.2022.1077180

Ejemplares similares